Yuan Ming Capital
Overview
Yuan Ming Capital is a venture capital firm specializing in the healthcare sector, with a focus on cross-border investments between China and the United States. The firm invests in therapeutics, medical devices, diagnostics, and healthcare service companies. It has offices in Beijing, Shenzhen, Suzhou, and Boston.
Portfolio Companies
7
Website
yuanmingcap.cnInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Chance Pharmaceuticals | Aug 2017 | Series D | Co-investor |
| Ansun BioPharma | Oct 2019 | Series B | Co-investor |
| Pharmacodia | May 2017 | Series B | Lead |
| PakGent Bioscience | Apr 2023 | Angel | Lead |
| Digital Health China Technologies | Jun 2018 | Series A | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Yuan Ming Capital based?
Yuan Ming Capital is headquartered in Beijing, Beijing, China.
When was Yuan Ming Capital founded?
Founding year information for Yuan Ming Capital is not publicly available.
How many portfolio companies does Yuan Ming Capital have?
Yuan Ming Capital has 7 portfolio companies in Caplight's dataset.
What are some companies in Yuan Ming Capital's portfolio?
Portfolio companies visible on Caplight include Chance Pharmaceuticals, Ansun BioPharma, Pharmacodia, PakGent Bioscience, Digital Health China Technologies.
What was Yuan Ming Capital's most recent investment shown here?
Yuan Ming Capital's most recent investment in this portfolio sample was in PakGent Bioscience in 2023.
What sectors does Yuan Ming Capital focus on?
Yuan Ming Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does Yuan Ming Capital focus on?
Stage focus information for Yuan Ming Capital is not publicly available.